GAMMEX® powder-free Gloves with AMT Antimicrobial Technology

anselleurope

GAMMEX® powder-free Gloves with AMT Antimicrobial Technology

Not oNly does it feel

like a secoNd skiN

it has its owN

immuNe system

kills >99% of

a hepatitis c virus surrogate

kills 99% of

hiv-1 straiN mn

kills >99.7% of

8 commoN iNfectious bacteria


Powder-free

pathogens are proven to transfer from healthcare workers to patients

and from patients to healthcare workers. 1,4

direct bacterial traNsmissioN

from the patient

in a majority of gloves with a breach

longer surgeries increase the risk of contamination

• hand bacterial counts are significantly higher with longer surgery time 2

double gloving reduces the risk of hand contamination, but does not eliminate it 4,5

• in 18% to 48% of cases, breaches occur in both the outer and inner gloves

HEALTHCArE workErS

CAN BE EXpoSED

To HArMfuL pATHoGENS

DurING SurGErY

• bacteria pass to the healthcare worker through glove breaches resulting from normal wear 1

45,5%

no bacterial

transmission

54,5%

bacterial transmission

references: 1. Hübner N-o, Goerdt A-M, Stanislawski N, et al. Bacterial migration through punctured surgical gloves under real surgical conditions. BMC Infect Dis. 2010;10:192. 2. Eklund AM, ojajärvi

J, Laitinen k, Valtonen M, werkkala kA. Glove punctures and postoperative skin flora of hands in cardiac surgery. Ann Thorac Surg. 2002;74:149-153. 3. Misteli H, weber wp, reck S, et al. Surgical

glove perforation and the risk of surgical site infection. Arch Surg. 2009;144:553-558. 4. Harnoß J-C, partecke L-I, Heidecke C-D, Hübner N-o, kramer A, Assadian o. Concentration of bacteria passing

through puncture holes in surgical gloves. Am J Infect Control. 2010;38:154-158. 5. Thomas S, Agarwal M, Mehta G. Intraoperative glove perforation—single versus double gloving in protection against

skin contamination. postgrad Med J. 2001;77:458-460. 6. Chan kY, Singh VA, oun BH, To BH. The rate of glove perforations in orthopaedic procedures: single versus double gloving. A prospective

study. Med J Malaysia. 2006;61(suppl B):3-7. 7. rabussay D, korniewicz DM. The risks and challenges of surgical glove failure. AorN J. 1997;66:867-888.


THE rISk for EXpoSurE

CAN BE EASY To MISS

the majority of glove breaches go unnoticed. 2,5,6

up to 83% of glove breaches

are Not Noticed by surgeoNs,

depending on the study 2,5,6

BrEACHES NoT

NoTICED

BY SurGEoN,%

80

60

40

20

0

CHAN kY,

et al. 6

EkLuND AM,

et al. 2

glove wear and tear, not sharps injuries, causes most breaches 6,7

• only 2% or less of all glove failures are caused by sharps injuries in most surgeries 7

• only 5% of noticed glove breaches are attributable to sharp surgical instruments in

orthopaedic surgeries 6

THoMAS S,

et al. 5

83%

69%

62%


THE fIrST SurGICAL GLoVE

THAT fIGHTS BACk

gammeX ® powder-free gloves with amt antimicrobial technology

reduce wearer exposure to pathogens.

a new level of antiviral protection

during in vitro laboratory testing, gammeX ® powder-free with amt:

• Kills >99% of a hepatitis c virus surrogate as early as 1 minute following exposure

• Kills 99% of hiv-1 strain mn * as early as 1 minute following exposure

rapid and lasting antibacterial action against a wide range of bacteria

during in vitro laboratory testing, gammeX ® powder-free with amt:

• Kills >99.7% to >99.999% of 8 common infectious bacteria causing healthcare

facility–associated infection, comprising gram-positive, gram-negative, and drug-resistant bacteria as early

as 1 and 2 minutes following exposure

in vivo laboratory testing confirms that the internal antimicrobial coating remains active against

staphylococcus aureus after 2 hours of wear.

Kills a wide range of pathogens

hiv

viruses

hepatitis c

virus surrogate

* hiv-1 strain mn is a well-studied, virulent strain of hiv-1.

mrsa

p. mirabilis

e. coli

bacteria

gram-positive

s. aureus

gram-negative

b. fragilis

e. faecium

K. oxytoca

a. baumannii


AMT ANTIMICroBIAL TECHNoLoGY

rEDEfINES pErforMANCE

ansell’s proprietary amt antimicrobial technology delivers added protection.

• ansell’s proprietary antimicrobial coating contains chlorhexidine gluconate (chg)

for antiviral and antibacterial action.

• chg is an effective antimicrobial agent found in common products such

as antiseptics and mouthwashes.

• antimicrobial action remains uncompromised when used with waterless

and water-aided surgical scrubs.

innovative technology

with a uNique structure

cross-sectioNal view

biopolymer overcoat

antimicrobial coating

containing chg

polymer coating

natural rubber latex

iNterNal surface/haNd

eXterNal surface

amt

antimicrobial technology

components

gammeX pf

base glove


MKTPRO190V1

powErfuL ANTIMICroBIAL ACTIoN

wITH A SofT TouCH

gammeX ® powder-free with amt combines antimicrobial action

with unsurpassed safety and comfort.

No distractiNg skiN irritatioN

• antimicrobial coating contains anti-irritants, moisturisers, and emollients to care for the hands

• no evidence of skin sensitisation observed during in vivo laboratory testing

• exceptionally low skin irritation level comparable to deionised water

• tested in accordance with iso 10993: biological evaluation of medical devices,

part 10: tests for irritation and delayed-type hypersensitivity

• extended product testing for enhanced quality assurance

gammeX ® powder-free with amt has a fit so natural,

it feels like a secoNd skiN

thinner, softer latex with

shaped finger pads

for further sensitivity

optimal thumb positioning and a

larger thumb ball for enhanced

comfort and reduced fatigue

tapered straight cuff for

improved gown grip

ansell healthcare europe n.v.

riverside business park block j boulevard international 55

b-1070 brussels belgium tel.: +32 (0) 2 528 74 00 fax: +32 (0) 2 528 74 01

fax: customer service +32 (0) 2 528 74 03

http://www.ansell.eu e-mail: info@ansell.eu

GAMMEX ® powder-free Gloves with AMT Antimicrobial Technology contain natural rubber latex, which may cause allergic reactions.

GAMMEX ® powder-free Gloves with AMT Antimicrobial Technology are not proven to protect against blood-borne infections where the

skin is broken, cut, or punctured. Australia patent No. 703926 and New Zealand patent No. 556353. Au and worldwide patents pending.

Ansell, ® and are trademarks owned by Ansell Limited or one of its affiliates. © 2011 Ansell Limited. All rights reserved.

produced on ansell’s proprietary

anatomic formers for

a more natural fit

wider, textured palm for

better instrument grip

in damp and dry environments

neither this document nor any other statement made herein by or on behalf of ansell should be construed as a warranty of merchantability or that any ansell product is fit for

a particular purpose. ansell assumes no responsibility for the suitability or adequacy of an end user’s selection of gloves for a specific application.

about aNsell

ansell is a world leader in providing superior health and safety protection solutions that enhance human well being. with operations in north america, latin america, emea

and asia, ansell employs more than 10,000 people worldwide and holds leading positions in the natural latex and synthetic polymer glove and condom markets. ansell

operates in four main business segments: medical solutions, industrial solutions, new verticals & advanced concepts, and sexual health & well being. information on ansell

and its products can be found at http://www.ansell.eu

YGAMMEXAMTDETEN / GAMMEXAMT DETAILAID EN / 5000 / 09-11 / SSBC

More magazines by this user
Similar magazines